{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:16:03Z","timestamp":1761585363670,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.intimp.2018.07.030","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T20:17:15Z","timestamp":1532636235000},"page":"14-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Progressive peripheral CD8+ T lymphocytosis complicated by pure red cell aplasia following immunosuppressive therapy for thymoma-associated myasthenia gravis"],"prefix":"10.1016","volume":"63","author":[{"given":"Rie","family":"Tabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-8887","authenticated-orcid":false,"given":"Chiharu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Yasumizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2018.07.030_bb0005","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1409::AID-CNCR7>3.0.CO;2-9","article-title":"T-cell lymphocytosis associated with lymphocyte-rich thymoma","volume":"80","author":"Barton","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2018.07.030_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12893-016-0171-0","article-title":"Bone metastasis of malignant thymomas associated with peripheral T-cell lymphocytosis","volume":"16","author":"Zhao","year":"2016","journal-title":"BMC Surg."},{"issue":"3","key":"10.1016\/j.intimp.2018.07.030_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5045\/br.2015.50.3.184","article-title":"Unusual association of CD8+ T-cell lymphocytosis with invasive thymoma","volume":"50","author":"Huh","year":"2015","journal-title":"Blood Res."},{"issue":"10","key":"10.1016\/j.intimp.2018.07.030_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","article-title":"Thymoma and thymic carcinoma: an update of the WHO classification 2004","volume":"35","author":"Str\u00f6bel","year":"2005","journal-title":"Surg. Today"},{"issue":"4","key":"10.1016\/j.intimp.2018.07.030_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.20021765","article-title":"In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells","volume":"197","author":"Yu","year":"2003","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2018.07.030_bb0030","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1073\/pnas.0809559106","article-title":"Characterization of the thymic IL-7 niche in vivo","volume":"106","author":"Alves","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2018.07.030_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2009.10.009","article-title":"Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells","volume":"32","author":"Nitta","year":"2010","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2018.07.030_bb0040","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2018.07.030_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.V100.1.159","article-title":"Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas","volume":"100","author":"Str\u00f6bel","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2018.07.030_bb0050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cei.12604","article-title":"Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells","volume":"180","author":"De Bruyne","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.07.030_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.21037\/jtd.2016.03.03","article-title":"Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma","volume":"8","author":"Song","year":"2016","journal-title":"Tuberculol. Thorac. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691830359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691830359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:45Z","timestamp":1761585045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691830359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":11,"alternative-id":["S156757691830359X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.07.030","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive peripheral CD8+ T lymphocytosis complicated by pure red cell aplasia following immunosuppressive therapy for thymoma-associated myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}